Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenues:
Total revenues	$ 51,253	$ 32,825	$ 140,490	$ 63,711
Expenses:
Cost of goods sold	3,995	5,021	14,749	11,922
Research and development	9,989	4,136	22,047	12,565
Selling	13,440	13,541	40,752	42,137
General and administrative	10,538	9,097	33,027	27,241
Gain on foreign currency transaction	(2,065)	(1,799)	(860)	(8,285)
Total expenses	46,156	42,435	139,670	115,031
Income (loss) from operations	5,097	(9,610)	820	(51,320)
Other income (expense):
Interest income, net	1,580	663	4,429	1,556
Interest expense on financing liability	(2,459)	(2,466)	(7,332)	(7,280)
Interest expense	(2,815)	(2,812)	(12,474)	(12,202)
Gain on available-for-sale securities			932
Other income (expense)	318	(207)	286	(207)
Total other expense	(3,376)	(4,822)	(14,159)	(18,133)
Income (loss) before income tax expense	1,721	(14,432)	(13,339)	(69,453)
Benefit from income taxes	0	0	0	0
Net income (loss)	$ 1,721	$ (14,432)	$ (13,339)	$ (69,453)
Net income (loss) per share - basic	$ 0.01	$ (0.06)	$ (0.05)	$ (0.27)
Net income (loss) per share - diluted	$ 0.01	$ (0.06)	$ (0.05)	$ (0.27)
Weighted average shares used to compute net income (loss) per share - basic	268,732	259,300	266,126	254,974
Weighted average shares used to compute net income (loss) per share - diluted	323,770	259,300	266,126	254,974
Commercial product sales
Revenues:
Total revenues	$ 17,927	$ 16,259	$ 53,834	$ 38,807
Collaborations and services
Revenues:
Total revenues	13,108	10,346	35,705	18,380
Expenses:
Cost of revenue	10,259	12,439	29,955	29,451
Royalties collaborations
Revenues:
Total revenues	$ 20,218	$ 6,220	$ 50,951	$ 6,524